Possible association between genetic polymorphisms in transforming growth factor β receptors, serum transforming growth factor β1 concentration and abdominal aortic aneurysm
✍ Scribed by J. Golledge; P. Clancy; G. T. Jones; M. Cooper; L. J. Palmer; A. M. van Rij; P. E. Norman
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 102 KB
- Volume
- 96
- Category
- Article
- ISSN
- 0007-1323
- DOI
- 10.1002/bjs.6633
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
Previous studies have suggested a role for transforming growth factor (TGF) β and its receptor in thoracic aortic aneurysm, but their role in abdominal aortic aneurysm (AAA) is unknown. This study examined the possible association between TGF-β receptor 1 and 2 (TGFBR-1 and -2) single nucleotide polymorphisms (SNPs) and serum TGF-β1 with AAA.
Methods
Serum concentrations of TGF-β1 and 58 SNPs for TGFBR-1 and -2 were examined in 1003 and 1711 men respectively from the Health In Men Study. Validation of SNPs was examined in a second referral cohort of 1043 subjects from New Zealand, of whom 654 had an AAA.
Results
Serum TGF-β1 was not associated with AAA. Only one SNP in TGFBR-2 was weakly associated with AAA; TGFBR2 g.42917C > T, SNP ID rs1078985CC; odds ratio 0·64 (95 per cent confidence interval (c.i.) 0·45 to 0·93); P = 0·020 uncorrected; but this association did not hold after adjusting for multiple testing and was not validated in the New Zealand cohort: odds ratio 0·98 (95 per cent c.i. 0·50 to 1·94); P = 0·960.
Conclusion
These findings suggest there is no important role of genetic polymorphisms in the main receptors for TGF-β and circulating TGF-β1 in AAA in older individuals.
📜 SIMILAR VOLUMES
## Abstract ## Objective To determine whether cytokine gene polymorphisms of interferon‐γ (IFNγ), interleukin‐6 (IL‐6), IL‐10, tumor necrosis factor α (TNFα), and transforming growth factor β1 (TGFβ1) predispose subjects to the development of primary Sjögren's syndrome (SS). ## Methods Single‐ba
## Background: Transforming growth factor-beta1 (tgf-beta1) acts as a potent inhibitor of cell growth and tumor progression but loss of this negative regulation can contribute to tumor development. some studies have reported an association between disease progression and tgf-beta1 expression in pat